boletraaz

Introduction to boletraaz

Boletraaz is a medication available in tablet form primarily used to treat certain types of cancer, such as kidney and breast cancer, and to prevent organ rejection after a transplant. Boletraaz works by slowing down the growth of cancer cells and suppressing the immune system to prevent rejection.

Composition of boletraaz

Boletraaz contains the active ingredient Everolimus, which functions by inhibiting a protein called mTOR. This protein is crucial for cell growth, and by blocking it, boletraaz helps in controlling the proliferation of cancer cells and modulating the immune response.

Uses of boletraaz

• Treatment of kidney cancer
• Treatment of breast cancer
• Prevention of organ rejection post-transplant

Side effects of boletraaz

• Common side effects: Mouth sores, infections, fatigue
• Serious side effects: Increased risk of infections, lung problems, kidney issues

Precautions of boletraaz

Before starting boletraaz, inform your doctor about any liver problems or allergies. Boletraaz can increase the risk of infections and may cause lung or kidney problems. It is not recommended for individuals with severe liver issues or those allergic to its components.

How to Take boletraaz

Boletraaz is typically taken as a tablet with an initial adult dose of 10 mg once daily. It should be taken orally, and your doctor may adjust the dose based on your response and any side effects. Always follow your doctor's instructions for the correct usage.

Conclusion of boletraaz

Boletraaz, containing the active ingredient Everolimus, belongs to the therapeutic class of mTOR inhibitors. It is manufactured to treat specific cancers and prevent organ rejection. Key highlights include its role in slowing cancer cell growth and modulating the immune system. For optimal results, follow your healthcare provider's guidance when using boletraaz.